Healthcare professionals should actively seek to understand individual patients’ perspectives on polypharmacy and its challenges, research in BMJ Open has concluded.
Fremanezumab safe and effective for preventing migraine over longer term, study suggestsSubscription
Patients with migraine continue to benefit from preventive treatment with fremanezumab over the longer term, with sustained reductions in monthly migraine and headache days, a study in Neurology has suggested.
Routine use of non-steroidal anti-inflammatory drugs might confer “modest” survival benefit for patients hospitalised with COVID-19 and is not associated with poorer outcomes, the results of a study published in the Journal of Clinical Medicine have suggested.
The clinical and microbiological outcomes of cefiderocol, a new antibiotic, were similar to the best available therapy for patients with life-threatening carbapenem-resistant infections, a phase III study has suggested.
Many patients who contract COVID-19 have detectable lung dysfunction 12 weeks after hospital discharge, results have suggested.
Addition of baricitinib to mainstay of treatment improves signs and symptoms of atopic dermatitis, study findsSubscription
Adding the oral selective Janus kinase 1 and 2 inhibitor, baricitinib, to topical corticosteroid treatment significantly improves the signs and symptoms of moderate-to-severe atopic dermatitis, a phase III study in JAMA Dermatology has suggested.
Prescribing asthma treatment based on genetic differences could improve outcomes, results presented at the European Respiratory Society International Congress have suggested.
Gaps between clinical guidelines and practice for lipid management in Europe, researchers findSubscription
Less than 60% of patients receiving lipid-lowering therapy achieve the low-density lipoprotein cholesterol levels set out in European guidelines.
Honey is superior to usual care for improving symptoms of upper respiratory tract infection symptoms, researchers have concluded.